Works matching DE "CALICHEAMICIN"

Results: 17

Crystal structure of O-methyltransferase CalO6 from the calicheamicin biosynthetic pathway: a case of challenging structure determination at low resolution.

Published in:

BMC Structural Biology, 2015, v. 15, p. 1, doi. 10.1186/s12900-015-0040-6

By:

Tsodikov, Oleg V.;
Caixia Hou;
Walsh, Christopher T.;
Garneau-Tsodikova, Sylvie

Publication type:

Article

Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis.

Published in:

Molecules, 2018, v. 23, n. 6, p. 1463, doi. 10.3390/molecules23061463

By:

Zimmermann, Tomas;
Christensen, Søren Brøgger;
Franzyk, Henrik;
Krchnak, Viktor

Publication type:

Article

Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment.

Published in:

2020

By:

Richardson, Paul G.;
Corbacioglu, Selim

Publication type:

Letter

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.

Published in:

Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0211-y

By:

Rafiee, Roya;
Chauhan, Lata;
Alonzo, Todd A.;
Wang, Yi-Cheng;
Elmasry, Ahlam;
Loken, Michael R.;
Pollard, Jessica;
Aplenc, Richard;
Raimondi, Susana;
Hirsch, Betsy A.;
Bernstein, Irwin D.;
Gamis, Alan S.;
Meshinchi, Soheil;
Lamba, Jatinder K.

Publication type:

Article

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 10, p. 2863, doi. 10.3109/10428194.2015.1017821

By:

Wagner-Johnston, Nina D.;
Goy, Andrè;
Rodriguez, Maria A.;
Ehmann, W. Christopher;
Hamlin, Paul A.;
Radford, John;
Thieblemont, Catherine;
Suh, Cheolwon;
Sweetenham, John;
Huang, Yifan;
Sullivan, Sharon T.;
Vandendries, Erik R.;
Gisselbrecht, Christian

Publication type:

Article

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia.

Published in:

AAPS Open, 2018, v. 4, n. 1, p. 0, doi. 10.1186/s41120-018-0021-5

By:

Jani, Darshana;
Nowak, John;
Chen, Ying;
Boni, Joseph;
Gorovits, Boris

Publication type:

Article

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia.

Published in:

Expert Review of Clinical Pharmacology, 2018, v. 11, n. 6, p. 549, doi. 10.1080/17512433.2018.1478725

By:

Baron, Jeffrey;
Wang, Eunice S.

Publication type:

Article

Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody-drug conjugates.

Published in:

Expert Review of Clinical Pharmacology, 2013, v. 6, n. 5, p. 541, doi. 10.1586/17512433.2013.827405

By:

Sapra, Puja;
Betts, Alison;
Boni, Joseph

Publication type:

Article

Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia.

Published in:

Annals of Hematology, 2015, v. 94, n. 3, p. 361, doi. 10.1007/s00277-014-2218-6

By:

Loke, J.;
Khan, J.;
Wilson, J.;
Craddock, C.;
Wheatley, K.

Publication type:

Article

Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.

Published in:

2018

By:

Kantarjian, Hagop M.;
Su, Yun;
Jabbour, Elias J.;
Bhattacharyya, Helen;
Yan, Eric;
Cappelleri, Joseph C.;
Marks, David I.

Publication type:

journal article

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.

Published in:

Cancer (0008543X), 2013, v. 119, n. 15, p. 2728, doi. 10.1002/cncr.28136

By:

Kantarjian, Hagop;
Thomas, Deborah;
Jorgensen, Jeffrey;
Kebriaei, Partow;
Jabbour, Elias;
Rytting, Michael;
York, Sergernne;
Ravandi, Farhad;
Garris, Rebecca;
Kwari, Monica;
Faderl, Stefan;
Cortes, Jorge;
Champlin, Richard;
O'Brien, Susan

Publication type:

Article

Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia.

Published in:

2019

By:

Hibma, Jennifer;
Knight, Beverly

Publication type:

journal article

Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Published in:

2019

By:

Masters, Joanna C.;
Barry, Elly;
Knight, Beverly

Publication type:

journal article

Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2012, v. 158, n. 5, p. 666, doi. 10.1111/j.1365-2141.2012.09192.x

By:

Yoshida, Nao;
Sakaguchi, Hirotoshi;
Matsumoto, Kimikazu;
Kato, Koji

Publication type:

Article

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00057

By:

Tirrò, Elena;
Massimino, Michele;
Romano, Chiara;
Pennisi, Maria Stella;
Stella, Stefania;
Vitale, Silvia Rita;
Fidilio, Annamaria;
Manzella, Livia;
Parrinello, Nunziatina Laura;
Stagno, Fabio;
Palumbo, Giuseppe Alberto;
La Cava, Piera;
Romano, Alessandra;
Di Raimondo, Francesco;
Vigneri, Paolo G.

Publication type:

Article

Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia.

Published in:

Blood & Lymphatic Cancer: Targets & Therapy, 2014, v. 4, p. 1, doi. 10.2147/BLCTT.S49048

By:

Thomas, Xavier

Publication type:

Article

AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin.

Published in:

PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053518

By:

Rosen, David B.;
Harrington, Kimberly H.;
Cordeiro, James A.;
Leung, Ling Y.;
Putta, Santosh;
Lacayo, Norman;
Laszlo, George S.;
Gudgeon, Chelsea J.;
Hogge, Donna E.;
Hawtin, Rachael E.;
Cesano, Alessandra;
Walter, Roland B.

Publication type:

Article